Introduction
The role of Clostridium difficile in inflammatory bowel disease and its relationship to sulphasalazine exposure is controversial. Studies from different parts of the world have suggested that it may cause relapse"2'3 whilst others have disputed this.4'5 '6 Sulphasalazine has been proposed as a predisposing factor7 and a protective factor.8 Variations in sampling, timing of collection, absence of either culture or toxin results, and population differences may contribute to some of the discrepancies in these studies. Detection of the organism or its toxin during a relapse of inflammatory bowel disease cannot necessarily implicate it in the causation of the relapse without taking into account the temporal relationship of its appearance during the attack in order that secondary acquisition can be excluded. Alternatively, changes in the faecal ecology secondary to the disease process may facilitate detection of the organism in inflammatory bowel disease.
Because of the diagnostic and therapeutic implications of this organism having a role in inflammatory bowel disease this study was 6 weeks). Thirty five patients were actively taking sulphasalazine, another 27 had received it at some time in the past, and 5 were receiving 5-amino salicylic acid.
Clostridium dificile was isolated under anaerobic conditions using CCFA Agar (Cefoxitin, Cycloserine, Fructose Agar). Toxin was detected by examining stool supernatant, for a cytopathic effect on HeLa cells which could be neutralized by Clostridium sordellii antitoxin. In addition stool was routinely cultured for salmonella, shigella and campylobacter species.
Results
Sixty two patients were able to supply a suitable stool sample prior to commencing treatment. Only 1 patient had a positive culture for Clostridium dificile but had no detectable stool toxin, he had been treated with cotrimoxazole for a chest infection and his symptoms resolved when the antibiotic was withdrawn. Another patient was found to be culture negative, but toxin was detected at very low titres (1:2), there had been no history of antibiotic exposure in this case. Only 4 patients had received antibiotics 1-2 months before the onset of their symptoms, and only 1 of these was culture positive.
There were 9 patients in whom no initial stool sample was obtained, but who provided a specimen during the course of treatment. All of these were negative for culture and toxin. Stools were assayed in a further 57 patients during treatment. Two cases were culture positive for Clostridium difficile but no toxin was detected. Both had received antibiotics during the treatment period, 1 patient in hospital the other as an outpatient. The inpatient was given vancomycin 125 mg t.d.s. orally on the basis of the positive culture result despite the fact that recovery from his colitis did not show any relapse in relation to antibiotic treatment or positive stool culture result. Three inpatients who required emergency colectomy were all Clostridium difficile negative at presentation. Six patients did not have Clostridium difficile culture or toxin assay before or during treatment but they all responded to treatment appropriate for their colitis. In no case was any other bacterial pathogen isolated before or during treatment.
Discussion
Reports in 1980 of an association with relapse of inflammatory bowel disease and the presence of Clostridium difficile or its toxin in the stool led to the suggestion that it might have a role in the relapse of IBD.'2 Further studies have both supported3 and refuted4'5'6 this view. Explanations put forward for the disparity in these reports have included population differences in patient groups, non-specificity of the toxin assays used, together with the absence ofsupportive culture results. The timing of cultures in relation to presentation and hospital admission has not been adequately documented and, because of this, stool Clostridium djifdcile positivity as a consequence of secondary acquisition during a period ofactive inflammation could not be excluded. Cultures obtained from hospitalized patients may represent nosocomial spread.'0"' In this study we have eliminated some of these problems by studying a group of patients whose diagnosis had been sigmoidoscopically and histologically substantiated, and by collecting samples before the patient was admitted to the hospital environment to eliminate nosocomial contamination. 
